To investigate the potential ac4C‐modified mRNA targets regulated by NAT10 in BLCA, acRIP‐sequencing (acRIP‐seq) assay was conducted using mRNA isolated from control and NAT10‐knockdown UMUC‐3 cell lines (Figure 3A). The gene discussed is NAT10; the disease is bladder transitional cell carcinoma.